These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 10065109)
1. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities]. Tsukagoshi S Gan To Kagaku Ryoho; 1999 Feb; 26(3):393-400. PubMed ID: 10065109 [TBL] [Abstract][Full Text] [Related]
4. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells. Ross DD; Cuddy DP Biochem Pharmacol; 1994 Oct; 48(8):1619-30. PubMed ID: 7980627 [TBL] [Abstract][Full Text] [Related]
5. Action of 2',2'-difluorodeoxycytidine on DNA synthesis. Huang P; Chubb S; Hertel LW; Grindey GB; Plunkett W Cancer Res; 1991 Nov; 51(22):6110-7. PubMed ID: 1718594 [TBL] [Abstract][Full Text] [Related]
6. Cellular pharmacology of gemcitabine. Mini E; Nobili S; Caciagli B; Landini I; Mazzei T Ann Oncol; 2006 May; 17 Suppl 5():v7-12. PubMed ID: 16807468 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells. Bouffard DY; Momparler LF; Momparler RL Anticancer Drugs; 1991 Feb; 2(1):49-55. PubMed ID: 1958852 [TBL] [Abstract][Full Text] [Related]
8. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase. Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028 [TBL] [Abstract][Full Text] [Related]
9. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells. Gandhi V; Mineishi S; Huang P; Yang Y; Chubb S; Chapman AJ; Nowak BJ; Hertel LW; Plunkett W Semin Oncol; 1995 Aug; 22(4 Suppl 11):61-7. PubMed ID: 7481847 [TBL] [Abstract][Full Text] [Related]
10. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro. Lech-Maranda E; Korycka A; Robak T Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114 [TBL] [Abstract][Full Text] [Related]
11. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076 [TBL] [Abstract][Full Text] [Related]
12. Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine. Xu YZ; Plunkett W Biochem Pharmacol; 1992 Nov; 44(9):1819-27. PubMed ID: 1449536 [TBL] [Abstract][Full Text] [Related]
13. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome. Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321 [TBL] [Abstract][Full Text] [Related]
14. Cell specific cytotoxicity and structure-activity relationship of lipophilic 1-B-D-arabinofuranosylcytosine (ara-C) derivatives. Peters GJ; Voorn DA; Kuiper CM; van der Wilt CL; Noordhuis P; Smid K; Myhren F; Sandvold M; Hendriks HR Nucleosides Nucleotides; 1999; 18(4-5):877-8. PubMed ID: 10432699 [TBL] [Abstract][Full Text] [Related]
15. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders. Santini V; Bernabei A; Gozzini A; Scappini B; Zoccolante A; D'Ippolito G; Figuccia M; Ferrini PR Haematologica; 1997; 82(1):11-5. PubMed ID: 9172997 [TBL] [Abstract][Full Text] [Related]
16. Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours. Ruiz van Haperen VW; Veerman G; Boven E; Noordhuis P; Vermorken JB; Peters GJ Biochem Pharmacol; 1994 Oct; 48(7):1327-39. PubMed ID: 7945430 [TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2',2'-difluorodeoxycytidine on human hepatoma HepG2 cells. Graziadei I; Kelly T; Schirmer M; Geisen FH; Vogel W; Konwalinka G J Hepatol; 1998 Mar; 28(3):504-9. PubMed ID: 9551690 [TBL] [Abstract][Full Text] [Related]
18. Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic. Bookman MA Int J Gynecol Cancer; 2005; 15 Suppl 1():12-7. PubMed ID: 15839953 [TBL] [Abstract][Full Text] [Related]
19. Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase. Bouffard DY; Laliberté J; Momparler RL Biochem Pharmacol; 1993 May; 45(9):1857-61. PubMed ID: 8494545 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. Beauséjour CM; Gagnon J; Primeau M; Momparler RL Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]